Access comprehensive trade data for Uab Farmlyga with ease. Explore trade shipments, top suppliers & buyers, and values without the hassle.
Eximpedia analyzes Uab Farmlyga export and import records, including data from 0 buyers and 1 suppliers. We provide an intelligence report of Uab Farmlyga that covers trade statistics, shipment values, quantities, exporters & importers and trade destinations
Uab Farmlyga import markets
Explore the Uab Farmlyga import market with monthly import values, major importers, HS Codes, key ports, top suppliers, and competitors
HS CODE | USD VALUE | SHIPMENTS | % |
---|---|---|---|
2936220000 | 4.05 | 2 | 2.08 |
PROVITAMINS AND VITAMINS, NATURAL OR REPRODUCED BY SYNTHESIS (INCLUDING NATURAL CONCENTRATES), DERIVATIVES THEREOF USED PRIMARESTDY AS VITAMINS, AND INTERMIXTURES OF THE FOREGOING, WHETHER OR NOT IN ANY SOLVENT | |||
3004900000 | 3.40 | 52 | 54.17 |
MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
3004490000 | 1.61 | 8 | 8.33 |
MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
2106909200 | 1.38 | 11 | 11.46 |
FOOD PREPARATIONS NOT ELSEWHERE SPECIFIED OR INCLUDED | |||
3004390000 | 0.56 | 14 | 14.58 |
MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS |
COUNTRY | USD VALUE | SHIPMENTS | % |
---|---|---|---|
CHINA | 4.05 | 2 | 2.08 |
ITALY | 1.45 | 4 | 4.17 |
EUROPEAN UNION | 1.45 | 13 | 13.54 |
BULGARIA | 0.97 | 18 | 18.75 |
SWITZERLAND | 0.95 | 12 | 12.50 |
PORT NAME | USD VALUE | SHIPMENTS | % |
---|---|---|---|
UA401020 | 10.60 | 93 | 96.88 |
UA110130 | 0.77 | 3 | 3.12 |
COMPANY | USD VALUE | SHIPMENTS |
---|---|---|
BAYER T RK KIMYA SANLTD TI | 1.63 | 2054 |
PRINOVA FOOD AND CHEMISTRY TRADE LIMITED COMPANY | 2.06 | 507 |
SANTA FARMA PHARMACEUTICALS SAN A | 2.08 | 643 |
LLC INSTITUTE OF BIOCHEMICAL TECHNOLOGIES | 4.06 | 166 |
SUIP IN THE FORM OF SPERCO UKRAINE LLC M VINYNYTSA STREET | 8.10 | 230 |
COMPANY | USD VALUE | SHIPMENTS |
---|---|---|
NO DISPONIBLE | 2.02 | 8443082 |
REFARMED CHEMICALS LIMITED | 2.08 | 333 |
PRINOVA EUROPE LIMITED | 2.19 | 779 |
LGC STANDARDS SP Z O O | 4.06 | 2046 |
UAB FARMLYGA | 8.10 | 96 |
If you are looking to establish relationship with Uab Farmlyga Automation you can save time by getting access to the key decision makers and get a detailed report.
Discover the Uab Farmlyga with product description, import values, quantities, exporter name, country of origin and key destinations.
HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
---|---|---|---|---|---|---|
3004900000 | 1. MEDICINAL PRODUCT PACKAGED FOR RETAIL TRADE ""RISPERON"" - 3840 P., DOSAGE FORM, DOSAGE: FILM-COATED TABLETS OF 4 MG EACH; ROUTE OF ADMINISTRATION: ORAL; INDICATIONS: TREATMENT OF SCHIZOPHRENIA AND OTHER MENTAL DISORDERS, INCLUDING SUPPORTIVE THERAPY, IN PATIENTS WHO HAVE RESPONDED TO THERAPY, WITH THE AIM OF PREVENTING DISEASE RELAPSE; SHORT-TERM TREATMENT OF SEVERE AGGRESSION OR SEVERE MENTAL SYMPTOMS IN PATIENTS WITH DEMENTIA WHEN THERE IS A THREAT OF HARMING THEMSELVES OR OTHERS; SYMPTOMATIC TREATMENT OF DEFIANT OPPOSITIONAL DISORDERS OR OTHER SOCIAL BEHAVIOR DISORDERS IN CHILDREN, ADOLESCENTS AND ADULTS WITH BELOW-AVERAGE MENTAL DEVELOPMENT OR MENTAL RETARDATION WHO HAVE MANIFESTATIONS OF DESTRUCTIVE BEHAVIOR (IMPULSIVITY, AUTO-AGGRESSION); SYMPTOMATIC TREATMENT OF AUTISTIC DISORDERS IN CHILDREN AGED 5 YEARS AND OLDER, IN WHICH SYMPTOMS RANGE FROM HYPERACTIVITY TO IRRITABILITY (INCLUDING AGGRESSION, SELF-INJURY, ANXIETY AND PATHOLOGICAL CYCLES" | BULGARIA | UKRAINE | 0 | ||
3004900000 | 1. MEDICINAL PRODUCT PACKAGED FOR RETAIL SALE ""NEUROTOP FL"" - 1423 UNITS, DOSAGE FORM, DOSAGE: SOLUTION FOR INJECTIONS, 50 MG/ML, 2 ML IN A BOTTLE; ROUTE OF ADMINISTRATION: INTRAMUSCULAR, INTRAVENOUS; INDICATIONS: ACUTE DISORDERS OF CEREBRAL CIRCULATION; DYSCIRCULATORY ENCEPHALOPATHY; NEUROCIRCULATORY DYSTONIA; BRAIN INJURY, CONSEQUENCES OF BRAIN INJURIES; MILD COGNITIVE DISORDERS OF ATHEROSCLEROTIC ORIGIN; ACUTE MYOCARDIAL INFARCTION (FROM THE FIRST DAY) - AS PART OF COMPLEX THERAPY; ANXIETY DISORDERS IN NEUROTIC AND NEUROTIC STATES; ABSTINENCE SYNDROME IN ALCOHOLISM WITH A PREDOMINANCE OF NEUROSIS-LIKE AND VEGETATIVE-VASCULAR DISORDERS; ACUTE INTOXICATION WITH ANTIPSYCHOTIC DRUGS; ACUTE PURULENT-INFLAMMATORY PROCESSES OF THE ABDOMINAL CAVITY (ACUTE NECROLYTIC PANCREATITIS, PERITONITIS) - AS PART OF COMPLEX THERAPY; PRIMARY OPEN-ANGLE GLAUCOMA (AT ALL STAGES) - AS PART OF COMPLEX THERAPY; AND THE SIZE OF THE PACKAGE: 2 ML IN A BOTTLE, 5 BOTTLES IN A CONTOUR CELL PACKAGE" | ARMENIA | UKRAINE | 0 | ||
3004390000 | 1. MEDICINAL PRODUCT CONTAINING HORMONES, PACKAGED FOR RETAIL SALE ""PROGYNORM OVO"" - 2592 UNITS, DOSAGE FORM, DOSAGE: 200 MG SOFT CAPSULES; ROUTE OF ADMINISTRATION: ORAL; INDICATIONS: DISORDERS ASSOCIATED WITH PROGESTERONE DEFICIENCY; HORMONE REPLACEMENT THERAPY IN MENOPAUSE (IN COMBINATION WITH ESTROGEN THERAPY); INFERTILITY WITH LUTEAL INSUFFICIENCY; PREVENTION OF HABITUAL MISCARRIAGE OR THREAT OF MISCARRIAGE AGAINST THE BACKGROUND OF LUTEAL INSUFFICIENCY; THE THREAT OF PREMATURE BIRTH; TYPE AND SIZE OF PACKAGING: 15 SOFT CAPSULES IN A BLISTER, 2 BLISTERS IN A PACK WITH MARKINGS IN UKRAINIAN; ACTIVE SUBSTANCE: PROGESTERONE 200 MG; AUXILIARY SUBSTANCES: PEANUT OIL, SOY LECITHIN; CAPSULE SHELL: GELATIN 150 BLOOM, GLYCERIN 99%, TITANIUM DIOXIDE (E 171); NOT IN AEROSOL PACKAGING AND DOES NOT CONTAIN OZONE-DEPLETING SUBSTANCES. SERIAL NO. LF31585A. COUNTRY OF MANUFACTURE ES, MANUFACTURER """"LABORATORIOS LEON FARMA SA"""", TRADEMARK - NO DATA.""" | SPAIN | UKRAINE | 0 | ||
3004390000 | 1. MEDICINAL PRODUCT CONTAINING HORMONES, PACKAGED FOR RETAIL SALE ""PROGYNORM GESTA"" - 714 UNITS, DOSAGE FORM, DOSAGE: SOFT CAPSULES OF 100 MG; ROUTE OF ADMINISTRATION: INTRAVAGINAL; INDICATIONS: DISORDERS ASSOCIATED WITH PROGESTERONE DEFICIENCY; TYPE AND SIZE OF PACKAGING: 15 SOFT CAPSULES IN A BLISTER, 2 BLISTERS IN A PACK WITH MARKINGS IN UKRAINIAN; ACTIVE SUBSTANCE: PROGESTERONE 100 MG; AUXILIARY SUBSTANCES: PEANUT OIL, SOY LECITHIN; CAPSULE SHELL: GELATIN 150 BLOOM, GLYCERIN 99%, TITANIUM DIOXIDE (E 171); NOT IN AEROSOL PACKAGING AND DOES NOT CONTAIN OZONE-DEPLETING SUBSTANCES. SERIAL NO. LF31388B. COUNTRY OF MANUFACTURE ES, MANUFACTURER """"LABORATORIOS LEON FARMA SA"""", TRADEMARK - NO DATA.""" | SPAIN | UKRAINE | 0 | ||
2936220000 | 1. ""COCARBOXYLASE CHLORIDE"" - 1350 KG., PHARMACEUTICAL RAW MATERIAL (VITAMIN B1), CHEMICAL NAME: 3-[(4-AMINO-2-METHYL-5-PYRIMIDINYL)METHYL]-5-[2-HYDROXY(PHOSPHONOXY) PHOSPHINYL-OXY-ETHYL]-4-METHYLTHIAZOLE HYDROCHLORIDE, CAS 154-87-0 IN THE FORM OF A WHITE OR ALMOST WHITE CRYSTALLINE OR FINE CRYSTALLINE POWDER WITH A WEAK SPECIFIC ODOR, BATCH 20230911. COUNTRY OF MANUFACTURE CN, MANUFACTURER """"SECOND PHARMA CO.,LTD """", TRADEMARK - NO DATA.""" | CHINA | UKRAINE | 0 | ||
3004900000 | 1. MEDICINAL PRODUCT PACKAGED FOR RETAIL SALE ""MIASER"" - 2447 UNITS, DOSAGE FORM, DOSAGE: FILM-COATED TABLETS, 10 MG EACH; ROUTE OF ADMINISTRATION: ORAL; INDICATIONS: DEPRESSIVE STATES OF VARIOUS ORIGINS; TYPE AND SIZE OF PACKAGING: 10 TABLETS IN BLISTERS, 2 BLISTERS IN A CARDBOARD PACK WITH MARKINGS IN UKRAINIAN; ACTIVE SUBSTANCE: MIANSERIN HYDROCHLORIDE 10 MG; AUXILIARY SUBSTANCES: CALCIUM HYDROGEN PHOSPHATE DIHYDRATE, METHYL CELLULOSE, COLLOIDAL ANHYDROUS SILICON DIOXIDE, MAGNESIUM STEARATE, CORN STARCH, PURIFIED WATER; FILM SHELL: SEPIFILM 752 WHITE (HYPROMELLOSE, MICROCRYSTALLINE CELLULOSE, POLYOXYL 40 STEARATE, TITANIUM DIOXIDE), MACROGOL 8000, PURIFIED WATER; NOT IN AEROSOL PACKAGING AND DOES NOT CONTAIN OZONE-DEPLETING SUBSTANCES. BATCH # 230483. COUNTRY OF MANUFACTURE CH, MANUFACTURER """"RIVOPHARM SA"""", TRADEMARK """"MIASER""""." | SWITZERLAND | UKRAINE | 0 | ||
2106909200 | 1. DIETARY SUPPLEMENT TO THE DIET ""LANEIRA"" 30 FILM-COATED TABLETS - 15080 UNITS, USED AS AN ADDITIONAL SOURCE OF NUTRIENTS FOR GENERAL STRENGTHENING OF THE BODY AND CREATION OF OPTIMAL DIETARY CONDITIONS FOR THE FUNCTIONING OF THE BODY, INCLUDING FOR THE PREVENTION OF DISORDERS OF THE NERVOUS SYSTEM, VESSEL WALLS, CONTAINS L - ACETYL-CARNITINE, ALPHA-LIPOIC ACID (THIOCTIC ACID), BLUEBERRIES, VITAMIN B6, B12, ZINC, SELENIUM; DOES NOT CONTAIN MILK FAT, SUCROSE, ISOGLUCOSE, GLUCOSE, STARCH, 15 TABLETS IN A BLISTER; 2 BLISTERS IN A PACK. SERIES 03636-04. COUNTRY OF MANUFACTURE IT, MANUFACTURER ""PNK FARMACEUTICI SRI"", TRADEMARK ""LANEIRA""""." | EUROPEAN UNION | UKRAINE | 0 | ||
3004390000 | 1. MEDICINAL PRODUCT CONTAINING HORMONES, PACKAGED FOR RETAIL SALE ""PROGYNORM GESTA"" - 822 UNITS, DOSAGE FORM, DOSAGE: 200 MG SOFT CAPSULES; ROUTE OF ADMINISTRATION: INTRAVAGINAL; INDICATIONS: DISORDERS ASSOCIATED WITH PROGESTERONE DEFICIENCY; TYPE AND SIZE OF PACKAGING: 15 SOFT CAPSULES IN A BLISTER, 2 BLISTERS IN A PACK WITH MARKINGS IN UKRAINIAN; ACTIVE SUBSTANCE: PROGESTERONE 200 MG; AUXILIARY SUBSTANCES: PEANUT OIL, SOY LECITHIN; CAPSULE SHELL: GELATIN 150 BLOOM, GLYCERIN 99%, TITANIUM DIOXIDE (E 171); NOT IN AEROSOL PACKAGING AND DOES NOT CONTAIN OZONE-DEPLETING SUBSTANCES. SERIAL NO. LF25696A. COUNTRY OF MANUFACTURE ES, MANUFACTURER """"LABORATORIOS LEON FARMA SA"""", TRADEMARK - NO DATA.""" | SPAIN | UKRAINE | 0 | ||
3004900000 | 1. MEDICINAL PRODUCT PACKAGED FOR RETAIL TRADE ""OPIPRAM"" - 23070UP., PHARMACEUTICAL FORM, DOSAGE: FILM-COATED TABLETS, 50 MG; ROUTE OF ADMINISTRATION: ORAL; INDICATIONS: GENERALIZED ANXIETY DISORDER; SOMATOPHORINE DISORDERS; TYPE, SIZE AND COMPLETENESS OF PACKAGING: 10 TABLETS IN BLISTERS; 3 BLISTERS IN A CARDBOARD PACK WITH UKRAINIAN LANGUAGE LABELING; ACTIVE INGREDIENTS: 1 TABLET CONTAINS 50MG OF OPIPRAMOL DIHYDROCHLORIDE; AUXILIARY INGREDIENTS: PREGELATINIZED STARCH, CELLULOSE, MICROCRYSTALLINE SILICON DIOXIDE, COLLOIDAL ANHYDROUS, MAGNESIUM STEARATE, MACROGOL 6000, HYPROMELLOSE, TALC, TITANIUM DIOXIDE (U 171), IRON OXIDE YELLOW (E 172). RIA NO. 404879. COUNTRY OF MANUFACTURE DE, MANUFACTURER """"DRAGENOPHARM APOTHEKERPUESCHL GMBH"", TRADEMARK - """"OPIPRAM | GERMANY | UKRAINE | 0 | ||
3004900000 | 1. MEDICINAL PRODUCT PACKAGED FOR RETAIL SALE ""NEUROTOP FL"" - 1120 UNITS, DOSAGE FORM, DOSAGE: SOLUTION FOR INJECTIONS, 50 MG/ML, 4 ML IN A BOTTLE; ROUTE OF ADMINISTRATION: INTRAMUSCULAR, INTRAVENOUS; INDICATIONS: ACUTE DISORDERS OF CEREBRAL CIRCULATION; DYSCIRCULATORY ENCEPHALOPATHY; NEUROCIRCULATORY DYSTONIA; BRAIN INJURY, CONSEQUENCES OF BRAIN INJURIES; MILD COGNITIVE DISORDERS OF ATHEROSCLEROTIC ORIGIN; ACUTE MYOCARDIAL INFARCTION (FROM THE FIRST DAY) - AS PART OF COMPLEX THERAPY; ANXIETY DISORDERS IN NEUROTIC AND NEUROTIC STATES; ABSTINENCE SYNDROME IN ALCOHOLISM WITH A PREDOMINANCE OF NEUROSIS-LIKE AND VEGETATIVE-VASCULAR DISORDERS; ACUTE INTOXICATION WITH ANTIPSYCHOTIC DRUGS; ACUTE PURULENT-INFLAMMATORY PROCESSES OF THE ABDOMINAL CAVITY (ACUTE NECROLYTIC PANCREATITIS, PERITONITIS) - AS PART OF COMPLEX THERAPY; PRIMARY OPEN-ANGLE GLAUCOMA (AT ALL STAGES) - AS PART OF COMPLEX THERAPY; AND THE SIZE OF THE PACKAGE: 4 ML IN A BOTTLE, 5 BOTTLES IN A CONTOURED ENVELOPE" | ARMENIA | UKRAINE | 0 | ||
3004900000 | 1. MEDICINAL PRODUCT PACKAGED FOR RETAIL TRADE ""SPORAXOL"" - 2740 UNITS, DOSAGE FORM, DOSAGE: 100 MG CAPSULES; ROUTE OF ADMINISTRATION: ORAL; INDICATIONS: VULVOVAGINAL CANDIDIASIS; LICHEN PLANUS; DERMATOMYCOSES CAUSED BY PATHOGENS SENSITIVE TO ITRACONAZOLE (TRICHOPHYTON SPP., MICROSPORUM SPP., EPIDERMOPHYTON FLOCCOSUM), SUCH AS DERMATOPHYTOSIS OF THE FEET, INGUINAL DERMATOPHYTOSIS, DERMATOPHYTOSIS OF THE TRUNK, DERMATOPHYTOSIS OF THE HANDS; OROPHARYNGEAL CANDIDIASIS; ONYCHOMYCOSES CAUSED BY DERMATOPHYTES AND/OR YEASTS; HISTOPLASMOSIS; SYSTEMIC MYCOSES (IN CASES WHERE FIRST-LINE ANTIFUNGAL THERAPY CANNOT BE APPLIED, OR IN CASE OF INEFFECTIVENESS OF TREATMENT WITH OTHER ANTIFUNGAL DRUGS, WHICH MAY BE DUE TO EXISTING PATHOLOGY, INSENSITIVITY OF THE PATHOGEN, OR DRUG TOXICITY): ASPERGILLOSIS AND CANDIDIASIS; CRYPTOCOCCOSIS (INCLUDING CRYPTOCOCCAL MENINGITIS): TREATMENT OF IMMUNOCOMPROMISED PATIENTS WITH CRYPTOCOCCOSIS AND ALL PATIENTS WITH CRYPTOCOCCOSIS OF THE CENTRAL NERVOUS SYSTEM; SUPPORTIVE" | SPAIN | UKRAINE | 0 | ||
3004900000 | 1. MEDICINAL PRODUCT PACKAGED FOR RETAIL TRADE ""MIASER"" - 2496 UNITS, DOSAGE FORM, DOSAGE: FILM-COATED TABLETS, 10 MG EACH; ROUTE OF ADMINISTRATION: ORAL; INDICATIONS: DEPRESSIVE STATES OF VARIOUS ORIGINS; TYPE AND SIZE OF PACKAGING: 10 TABLETS IN BLISTERS, 2 BLISTERS IN A CARDBOARD PACK WITH MARKINGS IN UKRAINIAN; ACTIVE SUBSTANCE: MIANSERIN HYDROCHLORIDE 10 MG; AUXILIARY SUBSTANCES: CALCIUM HYDROGEN PHOSPHATE DIHYDRATE, METHYL CELLULOSE, COLLOIDAL ANHYDROUS SILICON DIOXIDE, MAGNESIUM STEARATE, CORN STARCH, PURIFIED WATER; FILM SHELL: SEPIFILM 752 WHITE (HYPROMELLOSE, MICROCRYSTALLINE CELLULOSE, POLYOXYL 40 STEARATE, TITANIUM DIOXIDE), MACROGOL 8000, PURIFIED WATER; NOT IN AEROSOL PACKAGING AND DOES NOT CONTAIN OZONE-DEPLETING SUBSTANCES. BATCH # 223716. COUNTRY OF MANUFACTURE CH, MANUFACTURER """"RIVOPHARM SA"""", TRADEMARK """"MIASER""""." | SWITZERLAND | UKRAINE | 0 | ||
3004490000 | 1. MEDICINAL PRODUCT CONTAINING ALKALOIDS, PACKAGED FOR RETAIL ""TIONEX"" - 3108 UNITS, DOSAGE FORM, DOSAGE: TABLETS OF 8 MG; ROUTE OF ADMINISTRATION: ORAL; INDICATIONS: ADJUVANT THERAPY OF PAINFUL MUSCLE CONTRACTURES IN CASES OF ACUTE PATHOLOGIES OF THE SPINE IN ADULTS AND ADOLESCENTS OVER 16 YEARS OF AGE; TYPE, SIZE AND COMPLETENESS OF PACKAGING: 14 TABLETS IN A BLISTER; 1 BLISTER IN A CARDBOARD BOX WITH MARKINGS IN UKRAINIAN; ACTIVE INGREDIENT: 1 TABLET CONTAINS THIOCOLCHICOSIDE 8 MG; EXCIPIENTS: LACTOSE, MONOHYDRATE; MICROCRYSTALLINE CELLULOSE (TYPE 101); MICROCRYSTALLINE CELLULOSE (TYPE 102); POVIDONE (TYPE K30); COLLOIDAL ANHYDROUS SILICON DIOXIDE; CROSPOVIDONE (TYPE A); MAGNESIUM STEARATE. SERIES NO. 230607. COUNTRY OF MANUFACTURE PL, MANUFACTURER """"BIOFARM SP.Z OO"""", TRADEMARK - NO DATA.""" | POLAND | UKRAINE | 0 | ||
3304990000 | 1. ""ACEFLAN"" COSMETIC PRODUCT, CREAM OF 30 G - 3456 UNITS, INDICATIONS FOR USE: USED AS AN AUXILIARY AGENT, FOR TENDINITIS (INFLAMMATION OF TENDON TISSUE), ARTHRITIS, MYOFASCIAL PAIN SYNDROME (A SYNDROME CHARACTERIZED BY LONG-TERM PAIN IN THE FASCIA - M ""WHICH CONNECTIVE TISSUE); WITH PAIN IN DIFFERENT PARTS OF THE BACK; IN INFLAMMATORY CONDITIONS ASSOCIATED WITH LIMB INJURIES; WITH LIGAMENT SPRAINS AND HEMATOMAS (BRUISES); COMPOSITION: CORDIA OIL (CORDIA VERBENACEA) (ESSENTIAL OIL), CETOSTEARYL ALCOHOL, CETATE, DICAPRYLIC ETHER, SQUALENE HMTCH, DICAPRYLIC CARBONATE, GLYCERIN, METHYLPARABEN, PROPYLPARABEN, DISODIUM EDETATE DIHYDRATE AND PURIFIED WATER, 30 G EACH IN A TUBE IN A CARDBOARD BOX. BATCH 2305696. COUNTRY OF MANUFACTURE BR, MANUFACTURER """"ACHE LABORATORIOS FARMACEUTICOS SA"""", TRADEMARK """"ACHE""""." | BRAZIL | UKRAINE | 0 | ||
2106909200 | 1. DIETARY SUPPLEMENT TO THE DIET ""LANEIRA"" 30 FILM-COATED TABLETS - 13520 UNITS, USED AS AN ADDITIONAL SOURCE OF NUTRIENTS FOR GENERAL STRENGTHENING OF THE BODY AND CREATION OF OPTIMAL DIETARY CONDITIONS FOR THE FUNCTIONING OF THE BODY, INCLUDING FOR THE PREVENTION OF DISORDERS OF THE NERVOUS SYSTEM, VESSEL WALLS, CONTAINS L - ACETYL-CARNITINE, ALPHA-LIPOIC ACID (THIOCTIC ACID), BLUEBERRIES, VITAMIN B6, B12, ZINC, SELENIUM; DOES NOT CONTAIN MILK FAT, SUCROSE, ISOGLUCOSE, GLUCOSE, STARCH, 15 TABLETS IN A BLISTER; 2 BLISTERS IN A PACK. SERIES 03636-04. COUNTRY OF PRODUCTION IT, MANUFACTURER """"PNK FARMACEUTICI SRI"""", TRADEMARK """"PNK FARMACEUTICI""""." | EUROPEAN UNION | UKRAINE | 0 | ||
3004900000 | 1. MEDICINAL PRODUCT PACKAGED FOR RETAIL TRADE ""MITREN"" - 3564 UNITS, DOSAGE FORM, DOSAGE: 2 MG TABLETS; ROUTE OF ADMINISTRATION: ORAL; INDICATIONS: TREATMENT OF ENDOMETRIOSIS; TYPE AND SIZE OF PACKAGING: 28 TABLETS IN A BLISTER, 1 BLISTER IN A CARDBOARD BOX WITH LABELING IN UKRAINIAN; ACTIVE SUBSTANCE: DIENOGEST 2 MG; EXCIPIENTS: LACTOSE, MONOHYDRATE; CORN STARCH; POVIDONE K-30; MAGNESIUM STEARATE; NOT IN AEROSOL PACKAGING AND DOES NOT CONTAIN OZONE-DEPLETING SUBSTANCES. SERIAL NO. LF31196A. COUNTRY OF MANUFACTURE ES, MANUFACTURER """"LABORATORIOS LEON FARMA SA"""", TRADEMARK - NO DATA.""" | SPAIN | UKRAINE | 0 | ||
3004900000 | 1. MEDICINAL PRODUCT PACKAGED FOR RETAIL TRADE """"NEUROTOP FL""""- 4356UP., PHARMACEUTICAL FORM, DOSAGE: SOLUTION FOR INJECTION, 50MG/ML, 2ML IN A VIAL; ROUTE OF ADMINISTRATION: INTRAMUSCULAR, INTRAVENOUS; INDICATIONS: ACUTE DISORDERS OF CEREBRAL BLOOD CIRCULATION; DISCIRCULATORY ENCEPHALOPATHY; NEUROCIRCULATORY DYSTONIA; BRAIN INJURIES, CONSEQUENCES OF BRAIN INJURIES; MILD COGNITIVE DISORDERS OF ATHEROSCLEROTIC GENESIS; ACUTE MYOCARDIAL INFARCTION (FROM THE FIRST DAY) – AS PART OF COMPLEX THERAPY; ANXIETY DISORDERS IN NEUROTIC AND NEURO-LIKE STATES; ABSTINENCE SYNDROME IN ALCOHOLISM WITH PREDOMINANCE OF NEUROSE-LIKE AND VEGETATIVE-VASCULAR DISORDERS; ACUTE INTOXICATION BY ANTIPSYCHOTIC MEDICINES; ACUTE PUREUMATIC-INFLAMMATORY PROCESSES OF THE ABDOMINAL CAVITY (ACUTE NECROLYTIC PANCREATITIS, PERITONITIS) - AS PART OF COMPLEX THERAPY; PRIMARY OPEN-ANGLE GLAUCOMA (AT ALL STAGES) - AS PART OF COMPLEX THERAPY; AND PACKAGING SIZE: 2ML IN A VIAL, 5 VIALS IN A CONTOUR BLISTER, 1 CONTOUR BLISTER IN A CARDBOARD PACKAGE WITH UKRAINIAN LANGUAGE LABELING; ACTIVE INGREDIENT: ETHYL METHYLHYDROXYPYRIDINE SUCCINATE 50 MG; AUXILIARY SUBSTANCES: SODIUM METABISULPHITE, WATER FOR INJECTIONS; NOT IN AEROSOL PACKAGING AND DOES NOT CONTAIN OZONE DEPLETING SUBSTANCES. SERIES: № МХ021223- 1968UP; № МХ031223- 1938UP; NO. МХ041223-150UP; NO. МХ051223-150UP; NO. МХ061223-150UP. COUNTRY OF MANUFACTURE AM, MANUFACTURER CJSC ""LIQVOR"", TRADEMARK - NO DATA | ARMENIA | UKRAINE | 0 | ||
3004200000 | 1. MEDICINAL PRODUCT CONTAINING AN ANTIBIOTIC (CLINDAMYCIN), PACKAGED FOR RETAIL ""ULTREX"" - 2240 UNITS, DOSAGE FORM, DOSAGE: 300 MG CAPSULES; ROUTE OF ADMINISTRATION: ORAL; INDICATIONS: ACUTE AND CHRONIC BACTERIAL INFECTIONS CAUSED BY PATHOGENS SENSITIVE TO CLINDAMYCIN; TYPE AND SIZE OF PACKAGING: 8 SOFT CAPSULES IN A BLISTER, 2 BLISTERS IN A CARDBOARD BOX WITH MARKINGS IN UKRAINIAN; ACTIVE SUBSTANCE: CLINDAMYCIN 300 MG; EXCIPIENTS: LACTOSE, MONOHYDRATE; CORN STARCH; TALC; MAGNESIUM STEARATE; CAPSULE SHELL OF 150 MG: HARD GELATIN CAPSUGEL SIZE 1 (TITANIUM DIOXIDE (E 171), GELATIN, DYE 10A1 BLACK); CAPSULE SHELL: HARD GELATIN CAPSUGEL SIZE 0E1 (TITANIUM DIOXIDE (E 171), GELATIN, DYE 10A1 BLACK); NOT IN AEROSOL PACKAGING AND DOES NOT CONTAIN OZONE-DEPLETING SUBSTANCES. SERIES NO. 232222. COUNTRY OF MANUFACTURE CH, MANUFACTURER ""RIVOPHARM SA"", TRADEMARK ""ULTREKS""." | SWITZERLAND | UKRAINE | 0 | ||
3004390000 | 1. MEDICINAL PRODUCT CONTAINING HORMONES, PACKAGED FOR RETAIL SALE ""PROGYNORM GESTA"" - 2592 UNITS, DOSAGE FORM, DOSAGE: SOFT CAPSULES OF 200 MG; ROUTE OF ADMINISTRATION: INTRAVAGINAL; INDICATIONS: DISORDERS ASSOCIATED WITH PROGESTERONE DEFICIENCY; TYPE AND SIZE OF PACKAGING: 15 SOFT CAPSULES IN A BLISTER, 2 BLISTERS IN A PACK WITH MARKINGS IN UKRAINIAN; ACTIVE SUBSTANCE: PROGESTERONE 200 MG; AUXILIARY SUBSTANCES: PEANUT OIL, SOY LECITHIN; CAPSULE SHELL: GELATIN 150 BLOOM, GLYCERIN 99%, TITANIUM DIOXIDE (E 171); NOT IN AEROSOL PACKAGING AND DOES NOT CONTAIN OZONE-DEPLETING SUBSTANCES. SERIAL NO. LF32471A. COUNTRY OF MANUFACTURE ES, MANUFACTURER """"LABORATORIOS LEON FARMA SA"""", TRADEMARK - NO DATA.""" | SPAIN | UKRAINE | 0 | ||
3004490000 | 1. MEDICINAL PRODUCT CONTAINING ALKALOIDS, PACKAGED FOR RETAIL ""TIONEX"" - 7056 UNITS, DOSAGE FORM, DOSAGE: 8 MG TABLETS; ROUTE OF ADMINISTRATION: ORAL; INDICATIONS: ADJUVANT THERAPY OF PAINFUL MUSCLE CONTRACTURES IN CASES OF ACUTE PATHOLOGIES OF THE SPINE IN ADULTS AND ADOLESCENTS OVER 16 YEARS OF AGE; TYPE, SIZE AND COMPLETENESS OF PACKAGING: 14 TABLETS IN A BLISTER; 1 BLISTER IN A CARDBOARD BOX WITH MARKINGS IN UKRAINIAN; ACTIVE SUBSTANCE: 1 TABLET CONTAINS THIOCOLCHICOSIDE 8 MG; EXCIPIENTS: LACTOSE, MONOHYDRATE; MICROCRYSTALLINE CELLULOSE (TYPE 101); MICROCRYSTALLINE CELLULOSE (TYPE 102); POVIDONE (TYPE K30); COLLOIDAL ANHYDROUS SILICON DIOXIDE; CROSPOVIDONE (TYPE A); MAGNESIUM STEARATE. SERIES NO. 230811. COUNTRY OF MANUFACTURE PL, MANUFACTURER """"BIOFARM SP.Z OO"""", TRADEMARK """"TIONEX""""." | POLAND | UKRAINE | 0 |
No Pay, No Delay - 5 days Your Way!
Learn How our platform works in just 20 minutes!
Free Import-Export Sample data-One Click Away!
Our dedicated team of experts delivers current and flexible data from key global locations, enabling you to make essential decisions with vital information and insights.
We use bespoke layered visualizations for diving deep into our country and logistics data to provide your team with graphical assistance and essential data analysis and reporting.
All of our datasets are quality-controlled by layers of inspection before it ever reach your platform. This helps us maintain the high reliability our clients have come to trust.
Keep an eye out for any collaboration between your suppliers and your rivals, as this may impact their ability to satisfy your requirements.
With instant remote on-screen assistance, chat support, and user training, our customer success team is available to you around the clock.
Explore competitors' shipment histories, statistical and analytical reports, and country-specific information from more than 130 nations.
See all that you can accomplish with Eximpedia